Patent details

EP1368006 Title: NOVEL MODIFIED RELEASED FORMULATION

Basic Information

Publication number:
EP1368006
PCT Application Number:
PCT/SE/2002/000228
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027106459
PCT Publication Number:
WO/2002/064121
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL MODIFIED RELEASED FORMULATION
French Title of Invention:
NOUVELLE FORMULATION A LIBERATION MODIFIEE
German Title of Invention:
NEUE FORMULIERUNG MIT MODIFIZIERTER FREISETZUNG
SPC Number:

Dates

Filing date:
08/02/2002
Grant date:
03/05/2006
EP Publication Date:
03/05/2006
PCT Publication Date:
22/08/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/12/2003
EP B1 Publication Date:
03/05/2006
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/02/2009
Expiration date:
08/02/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/02/2002
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN JOELLE
From:
30/06/2006
Address:
ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
JUPPO Anne
Address:
Sweden (SE)

Priority

1

Priority Number:
0100477
Priority Date:
13/02/2001
Priority Country:
Sweden (SE)

2

Priority Number:
0100478
Priority Date:
13/02/2001
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 9/22;
Filing date Document type Number of pages